cardiovascular disease

Health Elizabeth Cooney

Sudden cardiac arrest requires luck to survive. Scientists hope to turn those odds around

Health Elizabeth Cooney

As Covid deaths drop, heart disease and cancer remain leading causes of death

A STAT Investigation Casey Ross, Lizzy Lawrence, Bob Herman, and Tara Bannow

STAT Plus: Health Care's Colossus: How UnitedHealth turned a questionable artery-screening program into a gold mine

Health Elizabeth Cooney

More heart patients getting prompt post-hospital care, but disparities increase

Biotech Elaine Chen

STAT Plus: Eli Lilly’s obesity drug Zepbound shows benefits in heart failure patients

Morning Rounds Theresa Gaffney

Morning Rounds: Grindr gets into health care lobbying

Health Rohan Rajeev

Vision loss and high cholesterol identified as risk factors for dementia

Health Elizabeth Cooney

New cardiovascular risk model could greatly decrease use of statins and increase heart attacks, study warns

In the Lab Deborah Balthazar

At a Mass General perfusion lab, a push to make more and more hearts viable for transplant

Biotech Allison DeAngelis

STAT Plus: Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund

Biotech Jason Mast

STAT Plus: Early data from Lexeo’s gene therapy for rare heart disease shows promise

Health Nicholas Florko

Medicaid is paying millions for salty, fat-laden ‘medically tailored’ cheeseburgers and sandwiches

Health Elizabeth Cooney

Q&A: The U.S. is losing control of hypertension. China’s ‘village doctors’ have lessons

Health tech Mario Aguilar

STAT Plus: AliveCor gets FDA nod for portable 12-lead, AI-powered ECG device

Health Rohan Rajeev

Despite risks, aspirin use remains high among older adults

Biotech Elaine Chen

STAT Plus: Alnylam reports positive results for heart drug in pivotal study, likely clearing path to approval

The Readout LOUD Allison DeAngelis and Adam Feuerstein

STAT Plus: Fauci’s memoir, Alnylam’s tenuous trial, and a mid-year review

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals

Health tech Lizzy Lawrence

STAT Plus: Boston Scientific to buy vascular device maker for $1.16 billion

Biotech Matthew Herper

STAT Plus: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease

Health Elizabeth Cooney

Lab experiment shows exactly how heat waves can put hearts into ‘oxygen debt’

Health Elizabeth Cooney

Millions fewer people may need statins, a new study suggests. But guidelines have yet to agree

Health Elizabeth Cooney

Study finds BMI, despite flaws, is useful estimate of body fat in children

Biotech Elaine Chen

STAT Plus: Ozempic cut risk of death in diabetes patients with chronic kidney disease

Health Elizabeth Cooney

Reversing progress, stroke rates are rising, especially in working-age adults

Biotech Matthew Herper and Elaine Chen

STAT Plus: Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575 million, lowering hopes of a buyout

Biotech Elaine Chen

STAT Plus: Amid acquisition speculation, Cytokinetics CEO stresses company can launch heart drug on its own

In the Lab Elizabeth Cooney

To detect risk of stroke, tiny probe acts ‘like a microscope’ inside brain’s blood vessels

Health tech Lizzy Lawrence

STAT Plus: Abbott’s dissolvable stent, which failed heart disease patients, may help vascular patients